China Healthcare Hong Kong Medicine Pharmaceutical Sourcing
In a groundbreaking development for the biopharmaceutical industry, the Hong Kong-listed AI drug discovery firm Insilico Medicine has clinched a monumental deal worth $2.5 billion with Korea’s SK Biopharmaceuticals. The….. Subscribe for Full Access! Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years! Subscribe! Share this Data
News Timeline:
Track the development of this news story across the Internet.